In vitro susceptibility of listeria monocytogenes comparison of the E test with the agar dilution test

Chemotherapy

Volumn 43, Issue 5, 1997, Pages 303-310

  Heger, Werenfrid ^a   Dierich, Manfred P ^a   Allerberger, Franz ^a  

^a UNIVERSITY OF INNSBRUCK   (Austria)

Author keywords

Agar dilution test; Etest; Listeria monocytogenes

Indexed keywords

AMPICILLIN; ANTIINFECTIVE AGENT; CEFALOTIN; CEFOTAXIME; CEFOXITIN; CEFPIROME; CEFTRIAXONE; CEFUROXIME; CEPHALOSPORIN DERIVATIVE; COTRIMOXAZOLE; GENTAMICIN; MEROPENEM; SULTAMICILLIN;

AGAR GEL DIFFUSION; ANTIBACTERIAL ACTIVITY; ANTIBIOTIC SENSITIVITY; ARTICLE; CONTROLLED STUDY; EPSILOMETER TEST; INTERMETHOD COMPARISON; LISTERIA MONOCYTOGENES; MINIMUM INHIBITORY CONCENTRATION; NONHUMAN; PRIORITY JOURNAL;

EID: 0030832331     PISSN: 00093157     EISSN: 14219794     Source Type: Journal    
DOI: 10.1159/000239582     Document Type: Article

References (48)

1. Allerberger F, Heger W, Dierich MP: Antimicrobial susceptibility of European Listeria monocytogenes isolates: Agar dilution test versus E-test. Abstracts of the IDSA 34th Annual Meeting, New Orleans. Infectious Diseases Society of America, 1996, pp 18.
2. American Type Culture Collection: Catalogue of Bacteria and Bacteriophages. ed 18. Washington. American Type Culture Collection, 1992.
3. Seeliger H: Listeriosis. New York, Karger, 1961.
4. Fcrone R, Bushby SRM, Burchall JJ, Moore WD, Smith D: Identification of Harper-Cawston factor as thymidine phosphorylase and removal from media of substances interfering with susceptibility testing to sulfonamides and diaminopyrid-ines. Antimicrob Agents Chcmother 1975;7:91-98.
5. National Committee for Clinical Laboratory Standards: Methods for Dilution Antimicrobial Susceptibility Tests for Bacteria that Grow Aerobically. Approved Standard M7-A3. Villanova, National Committee for Clinical Laboratory Standards. 1993.
6. National Committee for Clinical Laboratory Standards: Performance Standards for Antimicrobial Disk Susceptibility Test. Approved Standard. NCCLS document M2-A4. Villanova, National Committee for Clinical Laboratory Standards, 1990.
7. F. Test® technical Guide. 3 MIC Determination. Solna, Biodisk, 1993.
8. Martinez-Martinez L, Ortega MC, Suarez AI: Comparison of E test with broth microdilution and disk diffusion for susceptibility testing of coryncform bacteria. J Clin Microbiol 1995;33:1318-1321.
9. Jacobs MR, Bajaksozian S, Appcl-baum PC, Bolstrom A: Evaluation of the E test for susceptibility testing of pneumococci. Diagn Microbiol Infect Dis 1992;15:473-478.
10. Midolo PD, Tumidge J, Lambert JR, Bell JM: Validation of a modified Kirby-Bauer disk diffusion method for metronidazole susceptibility testing of Helicobacter pylori. Diagn M icrobiol I nfect Dis 1995;21: 135-140.
11. Citron DM, Ostavai MI, Karlsson A, Goldstein EJ: Evaluation of the E test for anaerobic bacteria. J Clin Microbiol 1991;29:2197-2203.
12. Wiggins GL, Albritton WL, Feeley JC: Antibiotic susceptibility of clinical isolates of Listeria monocytogenes. Antimicrob Agents Chcmother 1978;13:854-860.
13. Nichterlein T, Hof H: Effect of various antibiotics on Listeria monocytogenes multiplying in L929 cells. Infection 1991;19:234-238.
14. Barry AL, Jones RN: Comparison of cefadroxil and cephalothin disk susceptibility test results. J Clin Microbiol 1989;27:1460-1463.
15. Thomsberry C: Review of the in vitro antibacterial activity of cefpro-zil, a new oral cephalosporin. Clin Infect Dis 1992:14:189-194.
16. Kawaler B, Hof H: Failure of cephalosporins to cure experimental listeriosis. J Infect 1984:9:239-243.
17. MacGowan AP, Holt HA, Bywater MJ, Reeves DS: In vitro antimicrobial susceptibility of Listeria monocytogenes isolated in the UK and other Listeria species. Eur J Clin Microbiol Infect Dis 1990;9:767-770.
18. Thornsberry C: Review of in vitro activity of third-generation cephalosporins and other newer bcta-lac-tam antibiotics against clinically important bacteria. Am J Med 1985;79 (suppl. 2A): 14-20.
19. Hof H: Therapeutic activities of antibiotics in listeriosis. Infection 1991:19:229-233.
20. Espazc EP, Reynaud AE: Antibiotic susceptibilities of Listeria: In vitro studies. Infection 1988;16:160-164.
21. Marklcin G: Chemotherapie der Listeriose. Dtsch Med Wochenschr 1982;107:415-418.
22. Kayser FH, Morenzoni G, Strässlc A, Hadorn K: Activity of meropen-cm, against gram-positive bacteria. J Antimicrob Chemothcr 1989;24: 101-112.
23. Ahonkhai VI, Sierra MF, C'herubin CE, Shulman MA: The comparative activities of N-formimidoylthiena-mycin (MK0787), moxalactam, ce-fotaxim and cefoperazone against Yersinia enlerocolitica and Listeria monocytogenes. J Antimicrob Che-mother 1982:9:411-413.
24. Larrson S, Wälder MH, Cronberg SN, Forsgrcn AB, Moestrup T: Antimicrobial susceptibilities of Listeria monocytogenes strains isolated from 1958 to 1982 in Sweden. Antimicrob Agents Chcmother 1985; 28:12-14.
25. Duval J, Soussy CJ, Acar JF, Bre-gogne-Berezin E, Cluzcl R, Thabaut R, Courvalin P, Gres JJ. Rollin C: In-vitro antibacterial activity of ce-fepime: A multicentre study. J Antimicrob Chemothcr 1993;32:55-61.
26. Jones F.M, MacGowan AP: Antimicrobial chemotherapy of human infection due to Listeria monocytogenes. Eur J Clin Microbiol Infect bis 1995;14:165-175.
27. Vicente MF, Pcrez-Diaz C, Baqucro F, dePedro MA, Berenguer J: Penicillin-binding protein 3 of Listeria monocytogenes as the primary lethal target for p-lactams. Antimicrob Agents Chcmother 1990:34:539-542.
28. Hakenbcck R, Hof H: Relatedncss of penicillin-binding proteins from various Listeria species. FEMS Microbiol Lett 1991:84:191-196.
29. Hof H, Waldenmeier G: Therapy of experimental listeriosis - Evaluation of different antibiotics. Infection 1988:16:171-174.
30. Gauto AR, Cone LA, Woodard DR, Mahler RJ, Lynch RD, Stoltzman DH: Arterial infections due to Listeria monocytogenes: Report of four cases and review of world literature. Clin Infect Dis 1990;14:23-28.
31. Cone LA, Woodard DR, Gauto A: Listeriosis and cephalosporins -Reply. Clin Infect Dis 1992; 15:177-178.
32. Allerbcrgcr F, Guggenbichler JP: Listeriosis in Austria - Report of an outbreak in 1986. Acta Microbiol Hung 1989:36:149-152.
33. Allerberger F, Kasten MJ, Cockerill FR, Krismer M, Dierich MP: Listeria monocytogenes infection in prosthetic joints. Int Orthop 1992:16: 237-239.
34. Allerberger F, Dierich MP: Listeriosis and cephalosporins. Clin Infect Dis 1992;15:177-178.
35. Rapp MF, Pershadsingh HA, Long JW, Pickens JM: Ampicillin-resis-lant l.isteria monocytogenes meningitis in a previously healthy 14-ycar-old athlete. Arch Neurol 1984:41: 1304.
36. Pollock SS, Pollock TM, Harrison MJG: Ampicillin-rcsistant Listeria monocytogenes meningitis. Arch Neurol 1986:43:106.
37. Soriano F. Zapardicl, Nieto E: Antimicrobial susceptibilities of Cory-nebacterium species and other nonspore-forming gram-positive bacilli to 18 antimicrobial agents. Antimicrob Agents Chcmother 1995:39: 208-214.
38. MacGowan AP, Reeves DS, McLauchlin J: Antibiotic resistance of Listeria monocytogenes. Lancet 1990;336:513-514.
39. Charpentier E, Gerbaud G, Jacquet C, Rocourt J, Courcalin P: Incidence of antibiotic resistance in Listeria species. J Infect Dis 1995:172: 277-281.
40. Swaminathan B, Rocourt J, Bille J: Listeria; in Murray PR (ed): Manual of Clinical Microbiology. Washington, American Society for Microbiology, 1995, pp 342-348.
41. Nairn K, Shepherd GL, Edwards JR: Efficacy of mcropenem in experimental meningitis. J Antimicrob Chcmother 1995:36(suppl A):73-84.
42. Kluge RM: Listeriosis - Problems and therapeutic options. J Antimicrob Chcmother 1990;25:887-890.
43. Boisivon A, Guiomar C, Carbon C: In vitro bactericidal activity of amoxicillin, gentamicin. rifampicin. ciprofloxacin and trimcthoprim-sui-famethoxazolc alone or in combination against Listeria monocytogenes. Eur J Clin Microbiol Infect Dis 1990:9:206-209.
44. Rolston KIV, Bodey GP: Activity of new antimicrobial agents against Listeria monocytogenes. Eur J Clin Microbiol 1987;6:686-688.
45. MacGowan AP: Listeriosis - The therapeutic options. J Antimicrob Chemother 1990;26:721-730.
46. MacGowan AP, Holt HA, Reeves DS: In-vitro synergy testing of nine antimicrobial combinations against Listeria monocytogenes. J Antimicrob Chemother 1990:25:561-566.
47. Kawaler B, Hof H: Murine model for therapy of listeriosis in the compromised host. Chemotherapy 1985:31:366-371.
48. Spitzer RG, Hammer SM, Karchm-er AW; Treatment of Listeria monocytogenes infection with trimetho-prim-sulfamcthoxazole: A case report and review of the literature. Rev Infect Dis 1986;8:427-430.